NCI Announces First International Workshop on the Biology, Prevention, and Treatment of Relapse After Allogeneic HSCT

The National Cancer Institute (NCI) is planning a two-day workshop on the problem of relapse following allogeneic hematopoietic stem cell transplantation. This workshop will take place November 2-3, 2009, on the NIH campus in Bethesda, MD. The goal of the workshop is to generate key research questions for a planned Request for Applications (RFA) at NCI. Registration information is available at http://web.ncifcrf.gov/events/relapse/register.asp. The registration deadline is November 1.